Last updated: 5 months ago
Ascendis Pharma 6-K Report: Novo Nordisk Collaboration & $100M Milestone Insight
Discover Ascendis Pharma's latest 6-K report detailing a strategic collaboration with Novo Nordisk for metabolic disease solutions, including a $100M milestone payment opportunity.